METHOD FOR PHARMACOLOGICALLY TREATING PSYCHOGENOUS ERECTILE DYSFUNCTION

medicine. SUBSTANCE: method involves administering dihydroergotamine mezylate in tablets at a dose of 2.5 mg twice a day during 30 days to patients having psychogenous erectile dysfunction caused by increased catecholamine contents in peripheral blood determined during masturbation and after ejacula...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	AKOPJAN A.S, AMETOV A.S, STANKEVICH V.EH, KORJAKIN M.V
Format:	Patent
Sprache:	eng
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	medicine. SUBSTANCE: method involves administering dihydroergotamine mezylate in tablets at a dose of 2.5 mg twice a day during 30 days to patients having psychogenous erectile dysfunction caused by increased catecholamine contents in peripheral blood determined during masturbation and after ejaculation. EFFECT: prolonged treatment effectiveness.